527 related articles for article (PubMed ID: 28275165)
1. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
[TBL] [Abstract][Full Text] [Related]
2. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
3. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
[TBL] [Abstract][Full Text] [Related]
4. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
[TBL] [Abstract][Full Text] [Related]
5. The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia.
Gallo A; Pérez de Isla L; Charrière S; Vimont A; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Moulin P; Bruckert E; Mata P; Béliard S;
JACC Cardiovasc Imaging; 2021 Dec; 14(12):2414-2424. PubMed ID: 34274263
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry.
Pérez de Isla L; Arroyo-Olivares R; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Fuentes F; Mata N; Piedecausa M; Mañas MD; Sánchez Muñoz-Torrero JF; Miramontes-González JP; de Andrés R; Mauri M; Aguado R; Brea Á; Cepeda JM; Vidal-Pardo JI; Martínez-Faedo C; Barba MÁ; Argüeso R; Ruiz-Pérez E; Michán A; Arrieta F; Riestra Fernández M; Pérez L; Pinilla JM; Díaz-Soto G; Pintó X; Padró T; Badimón L; Mata P;
Rev Esp Cardiol (Engl Ed); 2020 Oct; 73(10):828-834. PubMed ID: 32201274
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry.
Bourbon M; Alves AC; Alonso R; Mata N; Aguiar P; Padró T; Mata P
Atherosclerosis; 2017 Jul; 262():8-13. PubMed ID: 28475941
[TBL] [Abstract][Full Text] [Related]
8. SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia.
Gallo A; Charriere S; Vimont A; Chapman MJ; Angoulvant D; Boccara F; Cariou B; Carreau V; Carrié A; Bruckert E; Béliard S;
Atherosclerosis; 2020 Aug; 306():41-49. PubMed ID: 32688103
[TBL] [Abstract][Full Text] [Related]
9. Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?
Mata P; Alonso R; Pérez de Isla L
Curr Opin Lipidol; 2018 Dec; 29(6):445-452. PubMed ID: 30382952
[TBL] [Abstract][Full Text] [Related]
10. Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype.
Ramos R; Masana L; Comas-Cufí M; García-Gil M; Martí-Lluch R; Ponjoan A; Plana N; Alves-Cabratosa L; Marrugat J; Elosua R; Dégano IR; Gomez-Marcos MA; Zamora A
Atherosclerosis; 2020 Jan; 292():42-51. PubMed ID: 31759248
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
12. A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort.
Pérez de Isla L; Watts GF; Muñiz-Grijalvo O; Díaz-Díaz JL; Alonso R; Zambón D; Fuentes-Jimenez F; Mauri M; Padró T; Vidal-Pardo JI; Barba MA; Ruiz-Pérez E; Michán A; Mediavilla JD; Hernandez AM; Romero-Jimenez MJ; Badimon L; Mata P;
Eur J Prev Cardiol; 2022 May; 29(5):795-801. PubMed ID: 34864959
[TBL] [Abstract][Full Text] [Related]
13. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
[TBL] [Abstract][Full Text] [Related]
14. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
[TBL] [Abstract][Full Text] [Related]
15. Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia.
Paquette M; Cariou B; Bernard S; Hegele RA; Gallo A; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2024 Feb; 44(2):505-512. PubMed ID: 38031840
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy.
Burke JP; Simpson RJ; Paoli CJ; McPheeters JT; Gandra SR
J Clin Lipidol; 2016; 10(6):1470-1480.e3. PubMed ID: 27919365
[TBL] [Abstract][Full Text] [Related]
17. Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients.
Pérez de Isla L; Alonso R; Argüeso R; Muñiz-Grijalvo O; Álvarez-Baños P; Badimón L; Watts GF; Mata P;
J Clin Lipidol; 2022; 16(5):733-736. PubMed ID: 35906178
[TBL] [Abstract][Full Text] [Related]
18. Familial hypercholesterolemia and cardiovascular disease in older individuals.
Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Tada MT; Lima IR; Filho WS; Chacra AP; Pereira AC; Krieger JE; Santos RD
Atherosclerosis; 2021 Feb; 318():32-37. PubMed ID: 33450476
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P;
J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281
[TBL] [Abstract][Full Text] [Related]
20. Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study.
Pérez de Isla L; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Miramontes JP; Fuentes F; Gómez de Diego JJ; González-Estrada A; Mata N; Saltijeral A; Barreiro M; Tomás M; de Andrés R; Argüeso R; Serrano Gotarredona MP; Navarro Herrero S; Perea Palazón RJ; de Caralt TM; Suárez de Centi LA; Zhilina S; Espejo Pérez S; Padró T; Mata P;
J Clin Lipidol; 2018; 12(4):948-957. PubMed ID: 29753733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
